Enterprise Value
3.494M
Cash
0.00
Avg Qtr Burn
N/A
Short % of Float
0.77%
Insider Ownership
0.65%
Institutional Own.
9.93%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Arimoclomol Details Niemann Pick Disease Type C | NDA Resubmission | |
Aldoxorubicin Details Pancreatic cancer | Phase 2 Update | |
Arimoclomol Details Inclusion Body Myositis | Failed Discontinued | |
Arimoclomol Details Amyotrophic lateral sclerosis | Failed Discontinued |